Erratum: Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans (Journal of Clinical Investigation (2006) 116, (1651-1659) DOI: 10.1172/JCI27890);Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans

Journal of Clinical Investigation

Volumn 116, Issue 6, 2006, Pages 1651-1659

  Rittershaus, Philipp C ^a   Kechichian, Talar B ^a   Allegood, Jeremy C ^b   Merrill Jr , Alfred H ^b   Hennig, Mirko ^c   Luberto, Chiara ^a   Del Poeta, Maurizio ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE GLUCOSYLTRANSFERASE; VIRULENCE FACTOR;

ALKALINITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; CELL CYCLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; ENVIRONMENT; FUNGAL STRAIN; FUNGUS GROWTH; GROWTH DISORDER; HOST; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHAGOLYSOSOME; PRIORITY JOURNAL;

EID: 33745204218     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI27890     Document Type: Erratum

References (45)

1. Casadevall, A., and Perfect, J.R. 1998. Cryptococcus neoformans. ASM Press. Washington, DC, USA. 351-380.
2. Feldmesser, M., Tucker, S., and Casadevall, A. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278.
3. Levitz, S.M., et al. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
4. Chretien, F., et al. 2002. Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J. Infect. Dis. 186:522-530.
5. Feldmesser, M., Kress, Y., Novikoff, P., and Casadevall, A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
6. Lee, S.C., Kress, Y., Zhao, M.L., Dickson, D.W., and Casadevall, A. 1995. Cryptococcus neoformans survive and replicate in human microglia. Lab. Invest. 73:871-879.
7. Tucker, S.C., and Casadevall, A. 2002. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 99:3165-3170.
8. Steenbergen, J.N., Shuman, H.A., and Casadevall, A. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:15245-15250.
9. Luberto, C., et al. 2001. Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. Genes Dev. 15:201-212.
10. Rodrigues, M.L., et al. 2000. Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth. Infect. Immun. 68:7049-7060.
11. Toledo, M.S., Suzuki, E., Levery, S.B., Straus, A.H., and Takahashi, H.K. 2001. Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants. Glycobiology. 11:105-112.
12. Leipelt, M., et al. 2001. Glucosylceramide synthases, a gene family responsible for the biosynthesis of glucosphingolipids in animals, plants, and fungi. J. Biol. Chem. 276:33621-33629.
13. Matsubara, T., Hayashi, A., Banno, Y., Morita, T., and Nozawa, Y. 1987. Cerebroside of the dimorphic human pathogen, Candida albicans. Chem. Phys. Lipids. 43:1-12.
14. Leipelt, M., Warnecke, D.C., Hube, B., Zahringer, U., and Heinz, E. 2000. Characterization of UDP-glucose: ceramide glucosyltransferases from different organisms. Biochem. Soc. Trans. 28:751-752.
15. Boas, M.H., Egge, H., Pohlentz, G., Hartmann, R., and Bergter, E.B. 1994. Structural determination of N-2′-hydroxyoctadecenoyl-1-O-beta-D- glucopyranosyl-9-methyl-4, 8-sphingadienine from species of Aspergillus. Chem. Phys. Lipids. 70:11-19.
16. Levery, S.B., et al. 2002. Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth. FEBS Lett. 525:59-64.
17. Toledo, M.S., Levery, S.B., Suzuki, E., Straus, A.H., and Takahashi, H.K. 2001. Characterization of cerebrosides from the thermally dimorphic mycopathogen Histoplasma capsulatum: expression of 2-hydroxy fatty N-acyl (E)-Delta(3)-unsaturation correlates with the yeast-mycelium phase transition. Glycobiology. 11:113-124.
18. Takahashi, H.K., et al. 1996. Isolation and possible composition of glucosylceramides from Paracoccidioides brasiliensis. Braz. J. Med. Biol. Res. 29:1441-1444.
19. Toledo, M.S., Levery, S.B., Glushka, J., Straus, A.H., and Takahashi, H.K. 2001. Structure elucidation of sphingolipids from the mycopathogen Sporothrix schenckii: identification of novel glycosylinositol phosphorylceramides with core manalpha1→6Ins linkage. Biochem. Biophys. Res. Commun. 280:19-24.
20. Warnecke, D., and Heinz, E. 2003. Recently discovered functions of glucosylceramides in plants and fungi. Cell. Mol. Life Sci. 60:919-941.
21. Hanada, K. 2005. Sphingolipids in infectious diseases. Jpn. J. Infect. Dis. 58:131-148.
22. Heung, L.J., Luberto, C., and Del Poeta, M. 2006. Role of sphingolipids in microbial pathogenesis. Infect. Immun. 74:28-39.
23. Pinto, M.R., et al. 2002. Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation. Glycobiology. 12:251-260.
24. Toledo, M.S., Suzuki, E., Straus, A.H., and Takahashi, H.K. 1995. Glycolipids from Paracoccidioides brasiliensis. Isolation of a galactofuranose-containing glycolipid reactive with sera of patients with paracoccidioidomycosis. J. Med. Vet. Mycol. 33:247-251.
25. Thevissen, K., et al. 2004. Defensins from insects and plants interact with fungal glucosylceramides. J. Biol. Chem. 279:3900-3905.
26. Nimrichter, L., et al. 2004. A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages. Microbes Infect. 6:657-665.
27. Toledo, M.S., et al. 1999. Characterization of sphingolipids from mycopathogens: factors correlating with expression of 2-hydroxy fatty acyl (E)-Delta 3-unsaturation in cerebrosides of Paracoccidioides brasiliensis and Aspergillus fumigatus. Biochemistry. 38:7294-7306.
28. Toledo, M.S., Levery, S.B., Straus, A.H., and Takahashi, H.K. 2000. Dimorphic expression of cerebrosides in the mycopathogen Sporothrix schenckii. J. Lipid Res. 41:797-806.
29. Villee, C.A. 1957. Biology. Saunders. Philadelphia, Pennsylvania, USA. 615 pp.
30. Levitz, S.M. 2001. Cryptococcus neoformans: intracellular or extracellular? Trends Microbiol. 9:417-418.
31. Saito, K., Takakuwa, N., Ohnishi, M., and Oda, Y. 2006. Presence of glucosylceramide in yeast and its relation to alkali tolerance of yeast. Appl. Microbiol. Biotechnol. 69:1-7.
32. Granger, D.L., Perfect, J.R., and Durack, D.T. 1985. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Invest. 76:508-516.
33. Klengel, T., et al. 2005. Fungal adenylyl cyclase integrates CO2 sensing with cAMP signaling and virulence. Curr. Biol. 15:2021-2026.
34. Klotz, S.A., Drutz, D.J., Huppert, M., Sun, S.H., and DeMarsh, P.L. 1984. The critical role of CO2 in the morphogenesis of Coccidioides immitis in cell-free subcutaneous chambers. J. Infect. Dis. 150:127-134.
35. Mogensen, E.G., et al. 2006. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1. Eukaryot. Cell. 5:103-111.
36. Bahn, Y.S., Cox, G.M., Perfect, J.R., and Heitman, J. 2005. Carbonic anhydrase and CO2 sensing during Cryptococcus neoformans growth, differentiation, and virulence. Curr. Biol. 15:2013-2020.
37. Ichikawa, S., Sakiyama, H., Suzuki, G., Hidari, K.I., and Hirabayashi, Y. 1996. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl. Acad. Sci. U. S. A. 93:4638-4643.
38. Marks, D.L., Dominguez, M., Wu, K., and Pagano, R.E. 2001. Identification of active site residues in glucosylceramide synthase. A nucleotide-binding catalytic motif conserved with processive beta-glycosyltransferases. J. Biol. Chem. 276:26492-26498.
39. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
40. Sullards, M.C., Lynch, D.V., Merrill, A.H., Jr., and Adams, J. 2000. Structure determination of soybean and wheat glucosylceramides by tandem mass spectrometry. J. Mass. Spectrom. 35:347-353.
41. Mandala, S.M., et al. 1995. The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity. J. Antibiot. (Tokyo). 48:349-356.
42. Merrill, A.H., Jr., Sullards, M.C., Allegood, J.C., Kelly, S., and Wang, E. 2005. Sphingolipidomics: high-throughput, structure-specific, and quantitative analysis of sphingolipids by liquid chromatography tandem mass spectrometry. Methods. 36:207-224.
43. Delaglio, F., et al. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:277-293.
44. Shaka, A.J., Lee, C.J., and Pines, A. 1988. Iterative schemes for bilinear operators; application to spin decoupling. J. Magn. Reson. 77:274-293.
45. Mersh, J.D., and Sanders, J.K.M. 1982. The suppression of Bloch-Siegert shifts and subtraction artifacts in double-resonance difference spectroscopy. J. Magn. Reson. 50:289-298.